Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

zoetis belgium sa-nv - oxytetracycline dihydrate 300 mg/ml - solution for injection - 300 mg/ml - oxytetracycline 300 mg/ml - oxytetracycline - cattle; pig

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

norbrook laboratories australia pty limited - oxytetracycline as the dihydrate; flunixin as flunixin meglumine - parenteral liquid/solution/suspension - oxytetracycline as the dihydrate antibiotic active 300.0 mg/ml; flunixin as flunixin meglumine benzene active 20.0 mg/ml - antibiotic & related - cattle | beef | bos indicus | bos taurus | bovine | buffalo | bull | bullock | calf | cow | dairy cow | heifer | steer - bovine respiratory disease | organisms sensitive to oxytetracycline | enteric bacterial infection | respiratory infection | shipping fever

Ireland - English - HPRA (Health Products Regulatory Authority)

norbrook laboratories limited - oxytetracycline basic - solution for injection - 300 mg/ml - oxytetracycline - bovine, ovine, porcine - antibacterial

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

norbrook laboratories australia pty limited - oxytetracycline as the dihydrate - parenteral liquid/solution/suspension - oxytetracycline as the dihydrate antibiotic active 300.0 mg/ml - antibiotic & related - cattle | pigs | sheep | beef | boar | bos indicus | bos taurus | bovine | buffalo | bull | bullock | calf | cow | dairy cow | ew - actinomyces pyogenes | antibiotics - oral, parenteral | atrophic rhinitis | bacterial infection | bacterial kerato conjunctivitis | bordetella bronchiseptica | chlamydia spp. | enzootic abortion | erysipelas infection | footrot - dichelobacter nodosus | infections of the respiratory tract | infections of the urinary tracts | mastitis | mycoplasma spp. | organisms sensitive to oxytetracycline | pasteurella spp. | pneumonia | protozoa | rickettsiae | staphylococcus spp. | streptococci | acute respiratory infections | airsacculitis | amoxycillin sensitive bacteria | anaerobic bacterial infection | associated with viral disease | avian mycoplasmas | bacterial pneumonia | bronchiseptica | bronchitis | canine cough syndrome | clavulanic acid sensitive | coccidiosis | coryza | crd | dermatoses | diarrhoea | endometritis | enteric bacterial infection | enteritis | enzootic pneumonia | escherichia coli | european brood disease | gentamicin sensitive | gram negative organisms | gram positive organisms | group d strepto

Ireland - English - HPRA (Health Products Regulatory Authority)

norbrook laboratories (ireland) limited - oxytetracycline dihydrate - solution for injection - 300 milligram(s)/millilitre - oxytetracycline

Ireland - English - HPRA (Health Products Regulatory Authority)

dechra regulatory b.v. - oxytetracycline; flunixin - solution for injection - oxytetracycline, combinations

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

probus pharmaceuticals pty ltd - oxytetracycline as the dihydrate - parenteral liquid/solution/suspension - oxytetracycline as the dihydrate antibiotic active 300.0 mg/ml - antibiotic & related

Israel - English - Ministry of Health

comex ltd - flunixin as meglumine; oxytetracycline as dihydrate - solution for injection - oxytetracycline as dihydrate 30 %w/v; flunixin as meglumine 2 %w/v - hexasol veterinary may be of use in the treatment of disease caused by microorgamisms sensitive to oxytetracycline where anti-inflammatory, anti-pyretic, and anti bacterial effect is required.

United States - English - NLM (National Library of Medicine)

norbrook laboratories limited - oxytetracycline (unii: x20i9en955) (oxytetracycline anhydrous - unii:slf0d9077s) - oxytetracycline 300 mg in 1 ml - noromycin 300 la is intended for use in treatment for the following diseases when due to oxytetracycline-susceptible organisms: beef cattle, non-lactating dairy cattle, calves, including pre-ruminating (veal) calves: noromycin 300 la is indicated in the treatment of pneumonia and shipping fever complex associated with pasteurella spp., and histophilus spp. noromycin 300 la is indicated for the treatment of infectious bovine keratoconjunctivitis (pink eye) caused by moraxella bovis, foot-rot and diphtheria caused by fusobacterium necrophorum; bacterial enteritis (scours) caused by escherichia coli; wooden tongue caused by actinobacillus lignieresii; leptospirosis caused by leptospira pomona; and wound infections and acute metritis caused by strains of staphylococcal and streptococcal organisms sensitive to oxytetracycline. also, it is indicated for the control of respiratory disease in cattle at high risk of developing brd associated with mannheimia (pasteurella) haemolytica. noromycin 300 la is indicat

United States - English - NLM (National Library of Medicine)

norbrook laboratories limited - oxytetracycline (unii: x20i9en955) (oxytetracycline - unii:x20i9en955), flunixin meglumine (unii: 8y3jk0jw3u) (flunixin - unii:356ib1o400) - oxytetracycline 300 mg in 1 ml - for the treatment of bacterial pneumonia associated with pasteurella spp. and for the control of associated pyrexia in beef and non-lactating dairy cattle. do not use in animals showing hypersensitivity to either flunixin meglumine or oxytetracycline.